311 related articles for article (PubMed ID: 21906588)
1. Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells.
Rhodes LV; Bratton MR; Zhu Y; Tilghman SL; Muir SE; Salvo VA; Tate CR; Elliott S; Nephew KP; Collins-Burow BM; Burow ME
Exp Cell Res; 2011 Nov; 317(18):2573-81. PubMed ID: 21906588
[TBL] [Abstract][Full Text] [Related]
2. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
Rhodes LV; Antoon JW; Muir SE; Elliott S; Beckman BS; Burow ME
Mol Cancer; 2010 Nov; 9():295. PubMed ID: 21087507
[TBL] [Abstract][Full Text] [Related]
3. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
4. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.
Rhodes LV; Short SP; Neel NF; Salvo VA; Zhu Y; Elliott S; Wei Y; Yu D; Sun M; Muir SE; Fonseca JP; Bratton MR; Segar C; Tilghman SL; Sobolik-Delmaire T; Horton LW; Zaja-Milatovic S; Collins-Burow BM; Wadsworth S; Beckman BS; Wood CE; Fuqua SA; Nephew KP; Dent P; Worthylake RA; Curiel TJ; Hung MC; Richmond A; Burow ME
Cancer Res; 2011 Jan; 71(2):603-13. PubMed ID: 21123450
[TBL] [Abstract][Full Text] [Related]
5. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
[TBL] [Abstract][Full Text] [Related]
7. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
Appaiah H; Bhat-Nakshatri P; Mehta R; Thorat M; Badve S; Nakshatri H
Cancer Biol Ther; 2010 Sep; 10(6):600-14. PubMed ID: 20603605
[TBL] [Abstract][Full Text] [Related]
8. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-381 Favors Repair of Nerve Injury Through Regulation of the SDF-1/CXCR4 Signaling Pathway via LRRC4 in Acute Cerebral Ischemia after Cerebral Lymphatic Blockage.
Piao JM; Wu W; Yang ZX; Li YZ; Luo Q; Yu JL
Cell Physiol Biochem; 2018; 46(3):890-906. PubMed ID: 29669322
[TBL] [Abstract][Full Text] [Related]
11. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
Hall JM; Korach KS
Mol Endocrinol; 2003 May; 17(5):792-803. PubMed ID: 12586845
[TBL] [Abstract][Full Text] [Related]
12. The SDF-1α/CXCR4 axis is required for proliferation and maturation of human fetal pancreatic endocrine progenitor cells.
Kayali AG; Lopez AD; Hao E; Hinton A; Hayek A; King CC
PLoS One; 2012; 7(6):e38721. PubMed ID: 22761699
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-induced SDF-1α production promotes the progression of ER-negative breast cancer via the accumulation of MDSCs in the tumor microenvironment.
Ouyang L; Chang W; Fang B; Qin J; Qu X; Cheng F
Sci Rep; 2016 Dec; 6():39541. PubMed ID: 27996037
[TBL] [Abstract][Full Text] [Related]
14. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
[TBL] [Abstract][Full Text] [Related]
15. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.
Yoshida D; Koketshu K; Nomura R; Teramoto A
J Neurooncol; 2010 Oct; 100(1):51-64. PubMed ID: 20309720
[TBL] [Abstract][Full Text] [Related]
16. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma.
Zhao BC; Wang ZJ; Mao WZ; Ma HC; Han JG; Zhao B; Xu HM
World J Gastroenterol; 2011 May; 17(19):2389-96. PubMed ID: 21633638
[TBL] [Abstract][Full Text] [Related]
17. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas.
Grymula K; Tarnowski M; Wysoczynski M; Drukala J; Barr FG; Ratajczak J; Kucia M; Ratajczak MZ
Int J Cancer; 2010 Dec; 127(11):2554-68. PubMed ID: 20162608
[TBL] [Abstract][Full Text] [Related]
18. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F
Int J Cancer; 2008 Jan; 122(1):91-9. PubMed ID: 17893878
[TBL] [Abstract][Full Text] [Related]
19. Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells.
Yi T; Zhai B; Yu Y; Kiyotsugu Y; Raschle T; Etzkorn M; Seo HC; Nagiec M; Luna RE; Reinherz EL; Blenis J; Gygi SP; Wagner G
Proc Natl Acad Sci U S A; 2014 May; 111(21):E2182-90. PubMed ID: 24782546
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis.
Gadalla R; Hassan H; Ibrahim SA; Abdullah MS; Gaballah A; Greve B; El-Deeb S; El-Shinawi M; Mohamed MM
Breast Cancer Res Treat; 2019 Apr; 174(3):679-691. PubMed ID: 30632021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
